Association of Dyslipidaemia and Ischaemic Heart Disease in Type II Diabetes Mellitus Patients: A Prospective Study

Author(s):  
Chandra Shekhar Srivastav
2004 ◽  
Vol 3 (3) ◽  
pp. 38-39
Author(s):  
Amiejo KR Sarma

The early detection of the myocardial manifestation in Diabetes Mellitus (DM) is of considerable importance, since the prognosis of patients with DM generally determined by the secondary cardiac complications. The aim of this study was to investigate whether asymptomatic patients with Type Il diabetes Mellitus without apparent clinical heart disease show any detectable abnormality in Echocardiography.


2007 ◽  
Vol 30 (1) ◽  
pp. 120-127 ◽  
Author(s):  
Majidreza Kamyar ◽  
B. Julienne Johnson ◽  
John J. McAnaw ◽  
Rosa Lemmens-Gruber ◽  
Steve A. Hudson

2014 ◽  
Vol 2014 ◽  
pp. 1-8 ◽  
Author(s):  
Marouane Boukhris ◽  
Salvatore Davide Tomasello ◽  
Francesco Marzà ◽  
Sonia Bregante ◽  
Francesca Romana Pluchinotta ◽  
...  

Coronary heart disease is the main cause of death in postmenopausal women (PMW); moreover its mortality exceeds those for breast cancer in women at all ages. Type II diabetes mellitus is a major cardiovascular risk factor and there is some evidence that the risk conferred by diabetes is greater in women than in men. It was established that the deficiency of endogenous estrogens promotes the atherosclerosis process. However, the impact of estrogen replacement therapy (ERT) on cardiovascular prevention remains controversial. Some authors strongly recommend it, whereas others revealed a concerning trend toward harm. This review tries to underlines the different components of cardiovascular risk in diabetic PMW and to define the place of ERT.


Sign in / Sign up

Export Citation Format

Share Document